Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2004 1
2005 1
2006 2
2007 3
2008 2
2009 2
2010 4
2012 1
2013 1
2014 2
2015 2
2016 4
2017 3
2018 3
2019 4
2020 1
2021 4
2022 7
2023 10
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: the randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial.
Mingrone G, van Baar AC, Devière J, Hopkins D, Moura E, Cercato C, Rajagopalan H, Lopez-Talavera JC, White K, Bhambhani V, Costamagna G, Haidry R, Grecco E, Galvao Neto M, Aithal G, Repici A, Hayee B, Haji A, Morris AJ, Bisschops R, Chouhan MD, Sakai NS, Bhatt DL, Sanyal AJ, Bergman JJGHM; Investigators of the REVITA-2 Study. Mingrone G, et al. Among authors: cercato c. Gut. 2022 Feb;71(2):254-264. doi: 10.1136/gutjnl-2020-323608. Epub 2021 Feb 17. Gut. 2022. PMID: 33597157 Free PMC article. Clinical Trial.
Cardiovascular risk and obesity.
Cercato C, Fonseca FA. Cercato C, et al. Diabetol Metab Syndr. 2019 Aug 28;11:74. doi: 10.1186/s13098-019-0468-0. eCollection 2019. Diabetol Metab Syndr. 2019. PMID: 31467596 Free PMC article. Review.
Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: A joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso).
Moreira RO, Valerio CM, Villela-Nogueira CA, Cercato C, Gerchman F, Lottenberg AMP, Godoy-Matos AF, Oliveira RA, Brandão Mello CE, Álvares-da-Silva MR, Leite NC, Cotrim HP, Parisi ER, Silva GF, Miranda PAC, Halpern B, Pinto Oliveira C. Moreira RO, et al. Among authors: cercato c. Arch Endocrinol Metab. 2023 Nov 27;67(6):e230123. doi: 10.20945/2359-4292-2023-0123. Arch Endocrinol Metab. 2023. PMID: 38048417 Review.
Combinations of drugs in the Treatment of Obesity.
Halpern B, Oliveira ES, Faria AM, Halpern A, Melo ME, Cercato C, Mancini MC. Halpern B, et al. Among authors: cercato c. Pharmaceuticals (Basel). 2010 Jul 27;3(8):2398-2415. doi: 10.3390/ph3082398. Pharmaceuticals (Basel). 2010. PMID: 27713360 Free PMC article. Review.
Obesity and obstructive sleep apnea-hypopnea syndrome.
de Sousa AG, Cercato C, Mancini MC, Halpern A. de Sousa AG, et al. Among authors: cercato c. Obes Rev. 2008 Jul;9(4):340-54. doi: 10.1111/j.1467-789X.2008.00478.x. Epub 2008 Mar 18. Obes Rev. 2008. PMID: 18363635 Review.
Consensus on pharmacological treatment of obesity in Latin America.
Cappelletti AM, Valenzuela Montero A, Cercato C, Duque Ossman JJ, Fletcher Vasquez PE, García García JE, Mancillas-Adame LG, Manrique HA, Ranchos Monterroso FM, Segarra P, Navas T. Cappelletti AM, et al. Among authors: cercato c. Obes Rev. 2024 Apr;25(4):e13683. doi: 10.1111/obr.13683. Epub 2023 Dec 20. Obes Rev. 2024. PMID: 38123524 Review.
51 results